On Tuesday, Gossamer Bio Inc (NASDAQ: GOSS) was -1.71% drop from the session before settling in for the closing price of $1.75. A 52-week range for GOSS has been $0.66 – $1.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 40.29% over the last five years. When this article was written, the company’s average yearly earnings per share was at -169.82%. With a float of $182.66 million, this company’s outstanding shares have now reached $227.22 million.
The firm has a total of 145 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -43.96%, and the pretax margin is -40.41%.
Gossamer Bio Inc (GOSS) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Gossamer Bio Inc stocks. The insider ownership of Gossamer Bio Inc is 19.64%, while institutional ownership is 58.21%.
Gossamer Bio Inc (GOSS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -169.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.90% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
You can see what Gossamer Bio Inc (GOSS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.24, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Analysing the last 5-days average volume posted by the [Gossamer Bio Inc, GOSS], we can find that recorded value of 3.68 million was better than the volume posted last year of 1.77 million. As of the previous 9 days, the stock’s Stochastic %D was 72.39%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 84.21%, which indicates a significant increase from 74.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1128 in the past 14 days, which was higher than the 0.1046 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2853, while its 200-day Moving Average is $1.0629. Now, the first resistance to watch is $1.7600. This is followed by the second major resistance level at $1.7999. The third major resistance level sits at $1.8449. If the price goes on to break the first support level at $1.6751, it is likely to go to the next support level at $1.6301. Now, if the price goes above the second support level, the third support stands at $1.5902.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
There are 227,302K outstanding shares of the company, which has a market capitalization of 390.96 million. As of now, sales total 114,700 K while income totals -56,530 K. Its latest quarter income was 9,890 K while its last quarter net income were -36,640 K.
